CIK 1274792

MERRIMACK PHARMACEUTICALS INC

EDGAR filings

Customers

1 disclosed

Suppliers

None disclosed

Largest customer

—

No % disclosed

Named-customer revenue

—

No estimate available

Latest period

Dec 31, 2016

10-K filed 2017-03-01

Band height is the estimated dollar value: the disclosed share × the discloser's revenue for that period (latest full year where available) or federal dollars obligated. Each side is scaled on its own; dashed outlines are named without a figure. Click a band to open its source.

Customers 2

Companies MERRIMACK PHARMACEUTICALS INC discloses as major customers, as a share of MERRIMACK PHARMACEUTICALS INC revenue. 1 active, 1 lapsed.

Company	% of MERRIMACK PHARMACEUTICALS INC revenue	Est. revenue	Period	Trend	Status	Source
SNY Sanofi	90%	$92.5M	FY 2014-12-31	−8.0pp	Lapsed Last seen 2014-12-31	10-K 2017-03-01
Sanofi — — 90% 10-K filed 2017-03-01 Period FY 2014-01-01 to 2014-12-31 (90%)Accession 0001564590-17-003026 Sanofi — 90% 98% 10-K filed 2016-02-26 Period FY 2013-01-01 to 2013-12-31 (98%)Accession 0001193125-16-480919 For each of the years ended December 31, 2013 and 2012, Sanofi represented greater than 98% of collaboration revenues. 10-K filed 2014-03-04 Period FY 2012-01-01 to 2012-12-31 (98%)Accession 0001193125-14-082294
CAH Distributor CARDINAL HEALTH INC	Named	—	FY 2016-12-31	—	Active	10-K 2017-03-01
Cardinal Health, Inc. 21% 16% 10-K filed 2017-03-01 Period FY 2016-01-01 to 2016-12-31, FY 2015-01-01 to 2015-12-31Accession 0001564590-17-003026

Alerts are coming

Get an email when MERRIMACK PHARMACEUTICALS INC's disclosed suppliers or customers change. Join the list and we'll tell you when alerts launch. One email, no spam.